6-hydroxyethoxzolamide has been researched along with alpha-chymotrypsin in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiang, CH; Kao, KD; Lu, DW; Wen, LY | 1 |
Chiang, CH; Huang, HS; Kao, KD; Lu, DW | 1 |
Barfknecht, CF; Eller, MG; Lewis, RA; Phelps, CD; Schoenwald, RD | 1 |
3 other study(ies) available for 6-hydroxyethoxzolamide and alpha-chymotrypsin
Article | Year |
---|---|
The study of ocular hypotensive effect of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
Topics: Animals; Benzothiazoles; Carbonic Anhydrase Inhibitors; Chymotrypsin; Disease Models, Animal; Ethoxzolamide; Female; Glaucoma; Intraocular Pressure; Male; Rabbits | 1990 |
Corneal and scleral penetration studies of 6-hydroxyethoxy-2-benzothiazole sulfonamide: a topical carbonic anhydrase inhibitor.
Topics: Administration, Topical; Animals; Aqueous Humor; Benzothiazoles; Carbonic Anhydrase Inhibitors; Chymotrypsin; Cornea; Ethoxzolamide; Female; Gels; Glaucoma; Male; Permeability; Rabbits; Sclera; Time Factors | 1990 |
Ethoxzolamide analogue gel. A topical carbonic anhydrase inhibitor.
Topics: Animals; Benzothiazoles; Carbonic Anhydrase Inhibitors; Chymotrypsin; Ethoxzolamide; Gels; Glaucoma; Intraocular Pressure; Ophthalmic Solutions; Rabbits; Suspensions; Thiazoles | 1984 |